A consecuencia de las fuertes presiones cada vez, más y más, las compañías farmacéuticas (USA) se ven obligadas a publicar el registro de sus pagos al cuerpo médico.
Acá podrás entrar y ver los pagos hechos por Lilly ($48.1 million) en el primer trimestre de 2011 a 45.440 médicos y 1.827 instituciones de salud.
De acuerdo a la nota que publica Marc Iskowitz (July 29, 2011) en Medical Marketing&Media:
It isn't the first to start disclosing TOVs. Pfizer earlier this year quantified payments on research and TOVs, saying it paid out $177 million to nearly 200,000 healthcare professionals in 2010, with 61% of that having gone to clinical trials "and related research and development expenses."
GlaxoSmithKline said it paid a total of $85.3 million last year to more than 5,000 US healthcare professionals for promotional talks or serving on advisory boards ($56.8 million) and to institutions for their help in conducting research ($28.5 million). And Merck said it paid $20.4 million last year to more than 2,000 US doctors and HCPs.
Entradas
No hay comentarios:
Publicar un comentario